(Q39790087)

14 September 2017

title

The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair (English)

1 reference

14 September 2017

1 reference

acute myeloid leukemia

1 reference

1 reference

P Maiso

1

1 reference

14 September 2017

E Colado

2

1 reference

14 September 2017

E M Ocio

3

1 reference

14 September 2017

M Garayoa

4

1 reference

14 September 2017

J Martín

5

1 reference

14 September 2017

P Atadja

6

1 reference

14 September 2017

A Pandiella

7

1 reference

14 September 2017

J F San-Miguel

8

1 reference

14 September 2017

publication date

8 October 2009

1 reference

14 September 2017

1 reference

14 September 2017

volume

23

1 reference

14 September 2017

issue

12

1 reference

14 September 2017

page(s)

2265-2274

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2009.182

14 September 2017

exact match

0 references

cites work

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Drug therapy for acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Chromatin modification, leukaemia and implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Regulation of histone deacetylase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Histone deacetylases and cancer: causes and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Histone acetylation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Histone deacetylase inhibitors: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Histone deacetylase inhibitors: molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Clinical development of histone deacetylase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Histone Deacetylase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Role for caspase-mediated cleavage of Rad51 in induction of apoptosis by DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Cell death: critical control points

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

The biochemistry of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.182

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2009.182

1 reference

release_pcpii3av4jaslpoynmnga6rt4y

14 September 2017

Fatcat ID

0 references

1 reference